Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Cancer Biotherapy & Radiopharmaceuticals
|
January 10, 2006
Isolation of scFvs to in vitro produced extracellular domains of EGFR family members
Eva Horak, Tara Heitner, Matthew K Robinson, et al.
Molecular Cancer Therapeutics
|
November 18, 2011
Single-chain antibody-based immunotoxins targeting Her2/neu: design optimization and impact of affinity on antitumor efficacy and off-target toxicity
Yu Cao, James D Marks, Qian Huang, et al.
ACS Nano
|
October 20, 2022
Ultrasmall Folate Receptor Alpha Targeted Enzymatically Cleavable Silica Nanoparticle Drug Conjugates Augment Penetration and Therapeutic Efficacy in Models of Cancer
Fei Wu, Pei-Ming Chen, Thomas C Gardinier, et al.
Plos Pathogens
|
November 8, 2008
Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway
Jianhua Sui, Daniel R Aird, Azaibi Tamin, et al.
Molecular Cancer Therapeutics
|
January 1, 2016
Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer
Andrea M Patterson, Saghar Kaabinejadian, Curtis P McMurtrey, et al.
Mabs
|
October 1, 2015
Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA
Paul W H I Parren, Dennis R Burton, Andrew Bradbury, et al.
Mabs
|
December 18, 2014
Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014
James W Larrick, Paul W H I Parren, James S Huston, et al.
Mabs
|
August 26, 2016
Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA
James W Larrick, Mark R Alfenito, Jamie K Scott, et al.
Cancer Discovery
|
November 6, 2012
Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation
Anna Sukhanova, Andrey Gorin, Ilya G Serebriiskii, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Cancer Biotherapy & Radiopharmaceuticals
|
January 10, 2006
Isolation of scFvs to in vitro produced extracellular domains of EGFR family members
Eva Horak, Tara Heitner, Matthew K Robinson, et al.
Molecular Cancer Therapeutics
|
November 18, 2011
Single-chain antibody-based immunotoxins targeting Her2/neu: design optimization and impact of affinity on antitumor efficacy and off-target toxicity
Yu Cao, James D Marks, Qian Huang, et al.
ACS Nano
|
October 20, 2022
Ultrasmall Folate Receptor Alpha Targeted Enzymatically Cleavable Silica Nanoparticle Drug Conjugates Augment Penetration and Therapeutic Efficacy in Models of Cancer
Fei Wu, Pei-Ming Chen, Thomas C Gardinier, et al.
Plos Pathogens
|
November 8, 2008
Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway
Jianhua Sui, Daniel R Aird, Azaibi Tamin, et al.
Molecular Cancer Therapeutics
|
January 1, 2016
Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer
Andrea M Patterson, Saghar Kaabinejadian, Curtis P McMurtrey, et al.
Mabs
|
October 1, 2015
Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA
Paul W H I Parren, Dennis R Burton, Andrew Bradbury, et al.
Mabs
|
December 18, 2014
Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014
James W Larrick, Paul W H I Parren, James S Huston, et al.
Mabs
|
August 26, 2016
Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA
James W Larrick, Mark R Alfenito, Jamie K Scott, et al.
Cancer Discovery
|
November 6, 2012
Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation
Anna Sukhanova, Andrey Gorin, Ilya G Serebriiskii, et al.
Page
of 4